Please login to the form below

Not currently logged in

Choosing wisely

How to make the best of emerging markets

The pill branding

An analysis of strategies for female emergency contraceptive pills finds major intercultural differences

Pharma deals in September 2015

Medius Deal Watch

Pharma deals in August 2015

Medius Deal WatchDuring a busy month AstraZeneca, Sanofi and Shire were among those hitting the headlines

Could EFPIA's new code boost pharma's reputation?

Rule changes for payments to doctors could present the industry with an opportunity


Authentic Engagement in Healthcare

Authentic Engagement in Healthcare thumbWhat does ‘authenticity’ mean to the healthcare sector and how can companies best build authentic relationships with their stakeholders?

Can medical technology afford market access?

Medical technologies should be innovative, unique, and have technical feasibility and robust intellectual property. This does not, however, guarantee successful market access and reimbursement.

Drivers for change – payer value perceptions

In an ever-changing healthcare environment, the need to prove value for money remains a key focus for payers and reimbursement decision makers.

Patient engagement: the future for outcomes research and clinical trials?

There is growing momentum and recognition among researchers, regulatory agencies, policy makers and payers towards a more patient-centric approach to health outcomes research, including development and validation of Clinical Outcome

Country reports

The death of the cancer drugs fund?

UK flagNHS England's siloed budget and its uncertain future

Is obesity really a problem in Brazil?

Obesity is on the rise in low- and middle-income countries, particularly in urban settings

Turkey: A growing pharma market with huge potential

The Turkish biopharma market offers many opportunities - if it can overcome its sustainability challenge


The challenge of antimicrobial resistance

Cubist Patrick-Vink Cubist's Patrick Vink on the company's ambitions in anti-infectives

Switching to a virtual healthcare system

babylon virtual health service Ali Parsa, CEO and founder of babylon, discusses the benefits of conducting healthcare consultations via a smartphone

The role of artificial intelligence in healthcare

Watson on jeopardy IBM's Amer Fasihi on the rise of Watson

White papers

What is a patient-centric brand anyway?

It’s hard to believe that in our industry, there have been ongoing rumblings about patient-centricity for years now. Sure, there are some great companies who have worked hard to bring

‘Less Is More: Making Patient-Centered Digital Communication a Reality’

Letizia Affinito writes on the Gower Publishing blog.

The Seven Cs Of Cross-Functional Brand Planning

As more and more organisations have moved to cross-functional and cross-regional involvement in the development of their strategic and operational brand plans, the result has been greater engagement and alignment,

2015/16 Pharmaceutical Titles

Browse our latest interactive Pharmaceutical and Healthcare catalogue

Featured jobs

Subscribe to our email news alerts


Add my company

eyeforpharma is a hub for senior-level pharma executives, patient advocacy groups and other health experts to exchange ideas and stay...